ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

NCI-Approved CTEP Trials For The Month of June

June 29, 2012

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

June 2, 2006

Mayo Clinic Develops New Jaw Reconstruction Method

August 25, 2006

RFAs For New Improve Accrual Of Minorities, Women

February 2, 1996

Survivorship Research RFA To Be Reissued; Biomedical Imaging Institute Names 10 to Advisory Council

November 29, 2002

Also in this 8-page issue: Vitamin E doesn’t prevent heart events, cancer, Women’s Health Study finds.

July 8, 2005